Insights into the enzymatic mechanism of 6-phosphogluconolactonase from Trypanosoma brucei using structural data and molecular dynamics simulation.

Trypanosoma brucei is the causative agent of African sleeping sickness. Current work for the development of new drugs against this pathology includes evaluation of enzymes of the pentose phosphate pathway (PPP), which first requires a clear understanding of their function and mechanism of action. In this context, we focused on T. brucei 6-phosphogluconolactonase (Tb6PGL), which converts delta-6-phosphogluconolactone into 6-phosphogluconic acid in the second step of the PPP. We have determined the crystal structure of Tb6PGL in complex with two ligands, 6-phosphogluconic acid and citrate, at 2.2 A and 2.0 A resolution, respectively. We have performed molecular dynamics (MD) simulations on Tb6PGL in its empty form and in complex with delta-6-phosphogluconolactone, its natural ligand. Analysis of the structural data and MD simulations allowed us to propose a detailed enzymatic mechanism for 6PGL enzymes.

[1]  Thomas A. Darden,et al.  Adventures in Improving the Scaling and Accuracy of a Parallel Molecular Dynamics Program , 1997, The Journal of Supercomputing.

[2]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[3]  C. E. Peishoff,et al.  A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.

[4]  P. Kollman,et al.  Automatic atom type and bond type perception in molecular mechanical calculations. , 2006, Journal of molecular graphics & modelling.

[5]  Wolfgang Kabsch,et al.  Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants , 1993 .

[6]  I. Gérin,et al.  Identification of the cDNA encoding human 6‐phosphogluconolactonase, the enzyme catalyzing the second step of the pentose phosphate pathway , 1999, FEBS letters.

[7]  F. Opperdoes.  Compartmentation of carbohydrate metabolism in trypanosomes. , 1987, Annual review of microbiology.

[8]  P. Kollman,et al.  A Second Generation Force Field for the Simulation of Proteins, Nucleic Acids, and Organic Molecules , 1995 .

[9]  Garib N. Murshudov,et al.  Model preparation in MOLREP and examples of model improvement using X-ray data , 2007, Acta crystallographica. Section D, Biological crystallography.

[10]  Celeste Sagui,et al.  P3M and PME: A comparison of the two methods , 1999 .

[11]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[12]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .

[13]  J. Périé,et al.  Glycolysis and proteases as targets for the design of new anti-trypanosome drugs. , 2002, Current topics in medicinal chemistry.

[14]  S J Wodak,et al.  SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model. , 1999, Acta crystallographica. Section D, Biological crystallography.

[15]  V. Lamzin,et al.  Assessment of automatic ligand building in ARP/wARP , 2006, Acta crystallographica. Section D, Biological crystallography.

[16]  J. Brannigan,et al.  Structure and Kinetics of a Monomeric Glucosamine 6-Phosphate Deaminase , 2005, Journal of Biological Chemistry.

[17]  Kevin Cowtan,et al.  research papers Acta Crystallographica Section D Biological , 2005 .

[18]  M. Delarue,et al.  Three dimensional structure and implications for the catalytic mechanism of 6-phosphogluconolactonase from Trypanosoma brucei. , 2007, Journal of molecular biology.

[19]  P. Kollman,et al.  Use of MM-PBSA in reproducing the binding free energies to HIV-1 RT of TIBO derivatives and predicting the binding mode to HIV-1 RT of efavirenz by docking and MM-PBSA. , 2001, Journal of the American Chemical Society.

[20]  E. Horjales,et al.  Structure and catalytic mechanism of glucosamine 6-phosphate deaminase from Escherichia coli at 2.1 A resolution. , 1995, Structure.

[21]  F. Opperdoes,et al.  NMR Spectroscopic Analysis of the First Two Steps of the Pentose-Phosphate Pathway Elucidates the Role of 6-Phosphogluconolactonase* , 2001, The Journal of Biological Chemistry.

[22]  M. Walkinshaw,et al.  Design, synthesis and trypanocidal activity of lead compounds based on inhibitors of parasite glycolysis. , 2008, Bioorganic & medicinal chemistry.

[23]  T. Darden,et al.  A smooth particle mesh Ewald method , 1995 .

[24]  P. Kollman,et al.  How well does a restrained electrostatic potential (RESP) model perform in calculating conformational energies of organic and biological molecules? , 2000 .

[25]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[26]  I. Gilbert,et al.  6-phosphogluconate dehydrogenase: a target for drugs in African trypanosomes. , 2004, Current medicinal chemistry.

[27]  J. Thornton,et al.  PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .

[28]  G. Ciccotti,et al.  Numerical Integration of the Cartesian Equations of Motion of a System with Constraints: Molecular Dynamics of n-Alkanes , 1977 .

[29]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[30]  H. Berendsen,et al.  ALGORITHMS FOR MACROMOLECULAR DYNAMICS AND CONSTRAINT DYNAMICS , 1977 .

[31]  S. Mowbray,et al.  Competitive Inhibitors of Mycobacterium tuberculosis Ribose-5-phosphate Isomerase B Reveal New Information about the Reaction Mechanism* , 2005, Journal of Biological Chemistry.